Physician profile
Victor Michael Marwin
NPI 1528325735
$86,094.36
in general payments reported to CMS, 2019-2025
11 companies · $15K in 2025
The $15K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $514 · 2023: $2,312 · 2024: $69K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Travel and Lodging: $17K · Food and Beverage: $7,866 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $60,725.00 |
| Travel and Lodging | $16,700.59 |
| Food and Beverage | $7,866.11 |
| Education | $288.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $83,243.38 | 2023-2025 | Sx-One Microknife |
| Arthrex, INC. | $1,206.69 | 2024-2025 | |
| Stryker Corporation | $476.07 | 2022-2025 | Blueprint Patient Specific Instrumentation, Iconix, Omega |
| Legacy Ortho LLC | $472.96 | 2022-2024 | |
| Skeletal Dynamics INC | $370.16 | 2023-2024 | Geminus, Ijs, Align |
| Depuy Synthes Sales INC. | $181.67 | 2022-2024 | Na, Lcp, Multiloc |
| Trice Medical, INC. | $73.33 | 2022 | |
| Endo USA, INC. | $20.66 | 2025 | Xiaflex |
| Dynasplint Systems INC. | $17.13 | 2025 | Dynasplint |
| Chiesi USA, INC. | $16.28 | 2023 | Cleviprex |
| Zimmer Biomet Holdings, INC. | $16.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Marwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.